Showing 1,601 - 1,620 results of 2,482 for search '"hepatitis"', query time: 0.08s Refine Results
  1. 1601

    Fusion protein-based COVID-19 vaccines exemplified by a chimeric vaccine based on a single fusion protein (W-PreS-O) by Pia Gattinger, Luibov I. Kozlovskaya, Alexander S. Lunin, Olga S. Gancharova, Dina I. Sirazova, Dina I. Sirazova, Vasiliy D. Apolokhov, Egor S. Chekina, Ilya V. Gordeychuk, Ilya V. Gordeychuk, Alexander V. Karaulov, Alexander V. Karaulov, Rudolf Valenta, Rudolf Valenta, Rudolf Valenta, Rudolf Valenta, Aydar A. Ishmukhametov, Aydar A. Ishmukhametov

    Published 2025-01-01
    “…The protein-based vaccine approach is exemplified solely in a proof of concept study by using W-PreS-O, a chimeric vaccine based on a single fusion protein (W-PreS-O), combining RBDs from Wuhan hu-1 wild-type and Omicron BA.1 with the hepatitis B virus (HBV)-derived PreS surface antigen adsorbed to aluminum hydroxide. …”
    Get full text
    Article
  2. 1602
  3. 1603
  4. 1604

    Combined Age with Mean Decrease Rates of Total Bilirubin and MELD Score as a Novel and Simple Clinical Predictor on 90-Day Transplant-Free Mortality in Adult Patients with Acute Li... by Di Jin, Kai Kang, Bing-zhu Yan, Jian-nan Zhang, Jun-bo Zheng, Zhi-hui Wang, Di Wu, Yu-jia Tang, Xin-tong Wang, Qi-qi Lai, Yang Cao, Hong-liang Wang, Yang Gao

    Published 2023-01-01
    “…Acute liver failure (ALF), previously known as fulminant hepatic failure, has become a common, rapidly progressive, and life-threatening catastrophic hepatic disease in intensive care unit (ICU) due to the continuous increase in drug abuse, viral infection, metabolic insult, and auto-immune cause. …”
    Get full text
    Article
  5. 1605

    Antenatal Care - How to ensure quality! by Lubna Ejaz

    Published 2023-09-01
    “…The quality of antenatal care was assessed in different dimensions by comparing the proportion of patients having an optimum number of antenatal visits, booking trimesters, effective screening for anemia, diabetes, hypertension, Hepatitis B & C, prophylaxis for tetanus, anemia and malnourishment, early diagnosis and prompt treatment of various obstetrical problems and the impact of these interventions on the fetomaternal outcomes. …”
    Get full text
    Article
  6. 1606

    Defining indicators for disease burden, health outcomes, policies and barriers and facilitators to health services for migrant populations in the Middle East and North African regi... by Charles Agyemang, Ali Ardalan, Farah Seedat, Bouchra Assarag, Nuria Casamitjana, Kolitha Wickramage, Sally Hargreaves, Ana Requena-Mendez, Fouad M Fouad, Dominik Zenner, Anna Deal, Stella Evangelidou, Wafa Saidi, Chiaki Ito, Oumnia Bouaddi, Moudrick Abdellatifi, Alba Cuxart-Graell, Hassan Edries, Eman Elafef, Taha Maatoug, Anissa Ouahchi, Liv Mathilde Pampiri, Sara Arias, Adel Abdelkhalek, Ahmed Hamed Arisha, Ibrahim Ahmed Bani, Aasmaa Chaoui, Wafa Chemao-Elfihri, Kenza Hassouni, Mahmoud Hilali, Mohamed Khalis, Wejdene Mansour, Ali Mtiraoui, MENA Migrant Health Working Group, Asad Adam, Adnene Ben Haj Aissa, Salma Altyib, Hanen Ben Belgacem, Imane Belkhammar, Thomas Calvot, Luciana Ceretti, Nelly Chavassieux, Hassan Chrifi, Mohamed Douagi, Algdail Elnil, Gonzalo Fanjul, Ahmed Hamed, Abdedayem Khelifi, Lora Makhlouf, Maissa Mokni, Davide Olchini, Tarik Oufkir, Nasong Park, Giuseppe Raffa, Sandra Santafé, Alice Sironi, Fatma Temimi, Zeineb Turki

    Published 2024-07-01
    “…This protocol describes a suite of seven systematic reviews that aim to identify, appraise and synthesise the available evidence on the burden and health outcomes, policies and access (barriers and facilitators) related to these mobile populations in the region.Methods Seven systematic reviews will cover three questions to explore the: (1) burden and health outcomes, (2) policies and (3) healthcare barriers and facilitators for the following seven disease areas in migrants in the MENA region: tuberculosis, HIV and hepatitis B and C, malaria and neglected tropical diseases, diabetes, mental health, maternal and neonatal health, and vaccine-preventable diseases. …”
    Get full text
    Article
  7. 1607
  8. 1608

    The Counteracting Effect of Chrysin on Dietary Fructose-Induced Metabolic-Associated Fatty Liver Disease (MAFLD) in Rats with a Focus on Glucose and Lipid Metabolism by Gabriela Campanher, Nelson Andrade, Joanne Lopes, Cláudia Silva, Maria João Pena, Ilda Rodrigues, Fátima Martel

    Published 2025-01-01
    “…When associated with the chow diet, chrysin reduced hepatic lipid and glycogen storage, increased the hepatic antioxidant potential of glutathione and reduced de novo lipogenesis in the adipose tissue. …”
    Get full text
    Article
  9. 1609
  10. 1610

    Zinc Supplementation Prevented Type 2 Diabetes-Induced Liver Injury Mediated by the Nrf2-MT Antioxidative Pathway by Lechu Yu, Yuanyuan Liu, Yichun Jin, Tinghao Liu, Wenhan Wang, Xuemian Lu, Chi Zhang

    Published 2021-01-01
    “…Additionally, we also observed that type 2 diabetes reduced hepatic MT expression, while zinc supplementation induced hepatic MT expression. …”
    Get full text
    Article
  11. 1611

    TNF-alpha but not IL-1alpha are Correlated with PGE1-Dependent Protection Against Acute D-Galactosamine-Induced Liver Injury by J Muntané, JL Montero, JM Lozano, A Miranda-Vizuete, M de la Mata, G Miño

    Published 2000-01-01
    “…BACKGROUND: Prostaglandin E1 (PGE1) treatment of humans and rodents during acute hepatic failure ameliorates different parameters of hepatic dysfunction.…”
    Get full text
    Article
  12. 1612

    Safe and Successful Yttrium-90 Resin Microsphere Radioembolization in a Heavily Pretreated Patient with Chemorefractory Colorectal Liver Metastases after Biliary Stent Placement ab... by Vlasios S. Sotirchos, Elena N. Petre, Karen T. Brown, Lynn A. Brody, Michael I. D’Angelica, Ronald P. DeMatteo, Nancy E. Kemeny, Constantinos T. Sofocleous

    Published 2014-01-01
    “…We report a case of safe and successful yttrium-90 resin microsphere radioembolization in a patient with a long history of multiple recurrent colon cancer hepatic metastases progressing after hepatic resections, hepatic arterial chemotherapy, and multiple regimens of systemic chemotherapy. …”
    Get full text
    Article
  13. 1613

    Diagnostic Imaging of Canine Hepatobiliary Affections: A Review by Vijay Kumar, Adarsh Kumar, A. C. Varshney, S. P. Tyagi, M. S. Kanwar, S. K. Sharma

    Published 2012-01-01
    “…Hepatic disease is often treatable and has a predictable prognosis when a definitive diagnosis is made. …”
    Get full text
    Article
  14. 1614

    Liver Injury Induced by Anticancer Chemotherapy and Radiation Therapy by Y. Maor, S. Malnick

    Published 2013-01-01
    “…We discuss the mechanism of the hepatic injury, secondary to reactive oxygen species, and the spectrum of hepatic injury including, steatosis, steatohepatitis, hepatic sinusoidal injury and highlight the pharmacogenomics of such liver insults. …”
    Get full text
    Article
  15. 1615

    Incidental Vascular Lesion in Explanted Liver: A Rare Case Report and Review of the Literature by Rossana Kazemimood, Shohreh Eliaszadeh, Kenneth Wind

    Published 2023-01-01
    “…Hepatic small vessel neoplasm (HSVN) is a rare vascular hepatic lesion that is usually an asymptomatic incidental finding. …”
    Get full text
    Article
  16. 1616

    Adrenal Rest Tumor of the Liver Preoperatively Diagnosed as Hepatocellular Carcinoma by Megumu Enjoji, Katsuya Sanada, Ryota Seki, Takashi Ito, Masato Maeda

    Published 2017-01-01
    “…Background. Hepatic adrenal rest tumors are rare and show similar findings to hepatocellular carcinoma (HCC). …”
    Get full text
    Article
  17. 1617

    Effects and Potential Mechanisms of Pioglitazone on Lipid Metabolism in Obese Diabetic KKAy Mice by Jun Peng, Yi Huan, Qian Jiang, Su-juan Sun, Chun-ming Jia, Zhu-fang Shen

    Published 2014-01-01
    “…Compared to C57BL/6J mice, KKAy mice developed obvious insulin resistance, hepatic steatosis, and hyperlipidemia. Pioglitazone treatment resulted in deteriorated microvesicular steatosis and elevated hepatic triglyceride levels, though plasma triglyceride and free fatty acid levels were reduced by the treatment, compared to nontreated KKAy mice. …”
    Get full text
    Article
  18. 1618

    The Role of the Liver in the Pathophysiology of PCOS: A Literature Review by Abrar Alhermi, Heather Perks, Varsha Nigi, Noor Altahoo, Stephen L. Atkin, Alexandra E. Butler

    Published 2025-01-01
    “…Several previous studies have shown a causal association between PCOS and hepatic disorders, such as chronic liver disease (CLD) and nonalcoholic fatty liver disease (NAFLD), where PCOS was identified as contributing to the hepatic features. …”
    Get full text
    Article
  19. 1619

    Major Histocompatibility Class II Pathway Is Not Required for the Development of Nonalcoholic Fatty Liver Disease in Mice by Gilles Willemin, Catherine Roger, Armelle Bauduret, Kaori Minehira

    Published 2013-01-01
    “…Firstly we studied the effect of high-fat diet-induced hepatic inflammation in these mice. Secondly we studied the development of carbon-tetra-chloride- (CCl4-) induced hepatic cirrhosis. …”
    Get full text
    Article
  20. 1620

    An Unusual Cause of Dyspnea and Thoracic Pressure by Claire Chakkalakal, Rezo Jorbenadze, Meinrad Gawaz

    Published 2019-01-01
    “…Complications include spontaneous hemorrhage, infection, thrombosis, and atrophy of surrounding hepatic tissue. We present a unique case of a middle-aged patient with acute onset of dyspnea and thoracic pressure due to compression of the right ventricle by a large hepatic cyst.…”
    Get full text
    Article